Home › Funds › Informed Momentum Co LLC › AMRX
Informed Momentum Co LLC position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Informed Momentum Co LLC reported holding 341,465 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.9M, representing 0.71% of its reported portfolio and ranking #19 among its reported holdings. Informed Momentum Co LLC has disclosed AMRX holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Informed Momentum Co LLC's AMRX position evolved
Informed Momentum Co LLC first disclosed a stake in AMRX in Q3 2023 at 230,271 shares (US$972K). The position peaked in Q3 2026 at 341,465 shares, worth US$6.9M. Across 4 filings, Informed Momentum Co LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 341,465 shares valued at US$6.9M — an increase of 3,802 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 230.27K | $971.74K | New |
| Q4 2025 | 425.72K | $5.36M | New |
| Q2 2026 | 337.66K | $5.84M | New |
| Q3 2026 | 341.46K | $6.88M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMRX and 13F data
AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 47 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Tri Locum Partners LP (US$46.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMRX
- TPG GP A, LLC 12.33M sh · $213.41M · Q2 2026
- Rubric Capital Management LP 10.17M sh · $176.02M · Q2 2026
- Tri Locum Partners LP 2.33M sh · $46.86M · Q3 2026
- Nantahala Capital Management, LLC 2.12M sh · $42.61M · Q3 2026
- Westshore Wealth, LLC 1.37M sh · $23.65M · Q2 2026
- PFM Health Sciences, LP 822.89K sh · $16.57M · Q3 2026
- Phocas Financial Corp. 819.48K sh · $14.19M · Q2 2026
More on Informed Momentum Co LLC
FAQ
How long has Informed Momentum Co LLC held AMRX?
Informed Momentum Co LLC has disclosed AMRX holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
What is Informed Momentum Co LLC's current position in AMRX?
As of Q3 2026, Informed Momentum Co LLC holds 341.46K shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $6.88M, representing 0.71% of its reported portfolio and ranking #19.
Has Informed Momentum Co LLC been buying or selling AMRX?
In the latest 13F filing (Q3 2026), Informed Momentum Co LLC increased its position in AMRX. The position peaked in Q3 2026 at 341.46K shares.
Which other funds hold AMRX?
Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Tri Locum Partners LP, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.